.svg)
Jane Myles, VP of Clinical Trial Innovation at Curebase, is embarking on a conversation that will sift through decentralized clinical trial standards and methodologies and discuss how the DCT ecosystem is evolving and will scale with new (and current) standards in place.
Over the last two years, the adoption of DCTs has taken off and with it comes variations in protocols and procedures. FDA standards that were once well understood in the clinical trial space can become blurred as technology adoption continues.
Additional panelists include Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), Lars-Olof “Lollo” Eriksson, Head of Clinical Development at Infant Bacterial Therapeutics AB, and Kimberly Barnholt, Senior Director and Evidence Generation Leader, Data-Systems at Genentech.
In this webinar, the group will be addressing what’s new in clinical trial standardization, what’s up and coming, and what’s the same. This webinar will touch on key topics including:
Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.
Jane Myles, VP of Clinical Trial Innovation at Curebase, is embarking on a conversation that will sift through decentralized clinical trial standards and methodologies and discuss how the DCT ecosystem is evolving and will scale with new (and current) standards in place.
Over the last two years, the adoption of DCTs has taken off and with it comes variations in protocols and procedures. FDA standards that were once well understood in the clinical trial space can become blurred as technology adoption continues.
Additional panelists include Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), Lars-Olof “Lollo” Eriksson, Head of Clinical Development at Infant Bacterial Therapeutics AB, and Kimberly Barnholt, Senior Director and Evidence Generation Leader, Data-Systems at Genentech.
In this webinar, the group will be addressing what’s new in clinical trial standardization, what’s up and coming, and what’s the same. This webinar will touch on key topics including:
Jane Myles, VP of Clinical Trial Innovation at Curebase, is embarking on a conversation that will sift through decentralized clinical trial standards and methodologies and discuss how the DCT ecosystem is evolving and will scale with new (and current) standards in place.
Over the last two years, the adoption of DCTs has taken off and with it comes variations in protocols and procedures. FDA standards that were once well understood in the clinical trial space can become blurred as technology adoption continues.
Additional panelists include Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), Lars-Olof “Lollo” Eriksson, Head of Clinical Development at Infant Bacterial Therapeutics AB, and Kimberly Barnholt, Senior Director and Evidence Generation Leader, Data-Systems at Genentech.
In this webinar, the group will be addressing what’s new in clinical trial standardization, what’s up and coming, and what’s the same. This webinar will touch on key topics including:
.svg)
We'd love to hear from you, whether a Sponsor interested in running a study with us, a provider looking to get involved in clinical research, or patients interested in our studies. Fill out your information below and one of our team members will be in touch.
Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.
%201.svg){kind=logo}
